Quote:GOPers Preemptively Trash CBO Before It Scores Their O'care Replacement
Quote:It's the facts cafeteria, folks. Where you never have to choose what's actually good for you.
LOL!
On Wednesday morning, two powerful House committees began marking up the bills to repeal the Affordable Care Act despite the fact that the non-partisan Congressional Budget Office (CBO) has not yet crunched the numbers on what the plan would cost or how many people would lose their health insurance if it passes.
The Republican authors of the bills refused to say this week if the number of uninsured Americans would grow or shrink under their proposals. Independent estimates of how many people would lose insurance range between two to four million and tens of millions of people.
As for how much the plan would cost the federal government, Republican leaders offered no numbers—only vague assurances that it will be "fiscally responsible."
House Speaker Paul Ryan (R-WI) told reporters Wednesday that he was not sure when the CBO would release its analysis of the bills, but said he hoped it would be next week, before the bill came to the House floor for a vote.
But ahead of that vague release date, rank-and-file Republicans are casting doubt on the agency's judgement.
"The CBO is consistently inconsistent," Sen. Tim Scott (R-SC) told TPM. "They can't predict the actual results of a 10-year window, because life changes so quickly. So I don't put that much weight on a CBO score."
Over on the House side, Rep. David Brat (R-VA) laughed when TPM asked about the rush to mark up the bill without knowing its cost or impact. "The CBO, they've scored everything wrong for decades," he said.
Emerging from a closed-door meeting of the Republican caucus, Rep. Glenn Thompson (R-PA) agreed. "To tell you the truth, the CBO, I don't see where they get it right," he told TPM. "I don't know what variables or parameters they use to score things. I don't have a lot of confidence in the CBO process."
Asked whose report he would rely on if not that of the non-partisan office, Thompson replied, "Trust me, this bill will be subject to all kinds of alternative analysis."
Yet, the alternative analyses released so far have not been favorable to the plan.
Standard & Poor’s estimated that 2-4 million people would drop out of the individual insurance market due to rising premium costs, and that another 4-6 million would lose their Medicaid coverage.
The Brookings Institution estimates that as many as 15 million people could lose coverage, largely because the repeal of the individual mandate would drive up costs for those who remain insured.
Former Rep. Mick Mulvaney (R-SC), the newly confirmed director of the Office of Management and Budget, promised Wednesday that when the CBO finally releases its score, it will be "really good" or "great." Others are not so sure, predicting the report will find that the bill would drive up the federal deficit and leave millions uninsured—a result that could "derail" the bill.
Ahead of that potential outcome, Republican lawmakers say that instead of the CBO score, they will rely on their own internal estimates of the plan's cost and impact on insurance prices.
"[Republican] leadership will put out something on the rate of growth, and they'll have to back it up with some spreadsheets or whatever," Brat assured TPM.
The CBO did not immediately respond to TPM's request for comment.
http://talkingpointsmemo.com/dc/republicans-say-no-to-cbo
ralph_vonholst
"To tell you the truth, the CBO, I don't see where they get it right," he told TPM. "I don't know what variables or parameters they use to score things. I don't have a lot of confidence in the CBO process."
So, I'm guessing you don't understand partial differential equations and stress/load analysis. And yet you blithely, without question, drive your car across bridges and fly in airplanes.
It's the facts cafeteria, folks. Where you never have to choose what's actually good for you.
sniffit
"Trust me, this bill will be subject to all kinds of alternative analysis."
"alternative analysis"
Need we say more?
jcblues
we want the CBO to use alt-scoring..
instead of calculating the cost of Dr visit and stitches when your kid gets cut just calculate the cost of band-aids..
given that vaccines cause spontaneous abortions and autism they won't need tetanus shots..
learn how to set your own broken arm.. apply splint..
after all Dr Carson leaned brain surgery
lowering costs for your benefit..
offer your own suggestions...
GOPers Preemptively Trash CBO Before It Scores Their O'care
Top 10 Most Recent News Articles
Qfin Holdings Faces Securities Fraud Class Action Challenges
Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...
Continue Reading
Eastern Championship: Collegiate Cricket's U.S. Surge
Cricket's American Dream Marches On Out of the woodwork comes the Collegiate Cricket League's 2026 Eastern Championship set to unfold near Washington, D.C., from Nov. 6-8. Now, nobody's saying cricket is overtaking the popularity of football or basketball stateside, but this three-day slugfest at Hal & Berni Hanson Regional Park in Aldie, Virginia, isn't just for...
Continue Reading
SAFE's New Website: Engineering Excellence and Faith
A Bold Digital Step for SAFE Structure Designs Now here's a move worth watching. SAFE Structure Designs, that U.S.-rooted defense contractor with its fingers in a multitude of engineering pies, just rolled out a fresh new face on the web. This isn't merely an online facelift; it's a declaration of ambition and capabilities. They're showcasing eight specialized divisions...
Continue Reading
Lumentum Holders Question Marvell Deal Fairness: Legal Eyes
What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...
Continue Reading
Crude Insight: Refining Margins Expand, LNG Orders Rise
Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...
Continue Reading
Farmer Sentiment Rises, Hints of Cautious Optimism
Sifting Through October's Optimism: Farmers' Sentiments October saw a glimmer of hope in the agricultural sector as the Purdue University/CME Group Ag Economy Barometer inched upward from 123 to 126. Sure, it's not a fireworks display, but it's a far cry from doom and gloom. This slim gain in sentiment comes on the coattails of some government help through Agriculture...
Continue Reading
BRIJ Medical Secures $5M: Paving Path for Product Launches
In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...
Continue Reading
China's Health-Driven Poverty Approach Offers Global Lessons
China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...
Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech
Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...
Continue Reading
Investors Slam Coastal Financial: Class Action Looms Large
The air's thick with tension as Coastal Financial Corporation (NASDAQ:CCB) finds itself embroiled in a securities class action lawsuit. Investors who grabbed shares between October 28, 2024, and July 29, 2026, are in the spotlight and urging those with losses to make a move by the December 1, 2026, lead plaintiff deadline. Sounds like a real mess, doesn't it? Well, it's a...
Continue ReadingTop 5 Most Recently Viewed Articles
Caribou Biosciences Investors Alerted to Class Action Lawsuit
Class Action Lawsuit Filed Against Caribou Biosciences, Inc. Recently, investors in Caribou Biosciences, Inc. (CRBU) were notified about a class action securities lawsuit that seeks to hold the company accountable for alleged investors' losses. The law firm Levi & Korsinsky, LLP is spearheading this lawsuit and is actively seeking participants who may have suffered...
Continue Reading
Investment Surge in Animal Parasiticides Market Ahead
Exploring the Growth of the Animal Parasiticides Market The Animal Parasiticides Market is experiencing a remarkable growth trajectory, projected to escalate from USD 10.80 billion in 2023 to an impressive USD 18.71 billion by 2032. This surge, at a compound annual growth rate (CAGR) of 6.32%, is fundamentally driven by various factors including the rising trend of pet...
Continue ReadingTrackerRMS Launches Innovative Onboarding+ Solution for Staffing
Introducing the New Onboarding+ Solution by TrackerRMS TrackerRMS has taken a significant step in revolutionizing the recruitment landscape with the introduction of its Onboarding+ solution. This innovative tool is designed specifically for recruitment agencies looking to enhance their onboarding process and improve the overall candidate journey. By integrating advanced...
Continue Reading
Bicycle Therapeutics: Promising Data Boosts Buy Rating and Target
Bicycle Therapeutics Receives Positive Rating Amid New Data H.C. Wainwright has recently reiterated a Buy rating for Bicycle Therapeutics (NASDAQ: BCYC), solidifying a $55.00 price target on the company's shares. This confidence follows the release of promising imaging data related to its lead internal candidate, showcasing significant potential in cancer diagnosis....
Continue Reading
Sonic Tools Relaunches Bigger, Smarter NEXT S15 Toolbox
Unlocking More Storage with the NEXT S15 Tool heads, grab your gears because Sonic Tools USA has blasted out its revamped NEXT S15 toolbox, the beefiest beast in their stable. Standing mighty at 46.5 inches high and stretching 65 inches wide, this toolbox bulges with a colossal capacity of more than a ton. It's the toolbox that acts like a sidekick—mobilized and ready...
Continue Reading